Abbott (NYSE: ABT) announced today that it received CE mark for its Esprit BTK everolimus-eluting resorbable scaffold system.

The FDA issued a notice outlining a serious recall of the Boston Scientific (NYSE:BSX) carotid WallStent monorail ...

Terumo announced today that it entered into a definitive agreement to acquire OrganOx and its organ preservation technology.

ProVerum announced today that it closed an $80 million Series B equity financing to support its benign prostatic hyperplasia ...

Otsuka Medical Devices announced that Japanese authorities approved the Recor Medical Paradise ultrasound renal denervation ...

Onward Medical announced today that it received FDA investigational device exemption (IDE) for its ARC-IM system.

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Restor3d announced today that it entered into a strategic investment partnership with global private market firm Partners ...

Solventum (NYSE:SOLV) today announced that it commenced offers to purchase outstanding notes for up to $1.75 billion.

Novocure announced today that it submitted an FDA premarket approval (PMA) application for its tumor-treating fields therapy.

CMR Surgical announced today that it appointed Chris O'Hara to its new role of commercial president & GM in the U.S.

Boston Scientific announced today that it initiated a new trial to assess its Agent DCB compared to the standard of care.